Hemostats Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Hemostats Market
Hemostats Market: By Type (Active, Passive, Flowable, Sealants and Adhesive), By Treatment (Cardiac Surgery, Vascular Procedure, Soft Tissue Reconstruction, Spinal Procedures, Hepatic Resection, and others), By End User (Hospitals, Surgery Centers, Nursing Homes, and Others) & By Geography Forecast (2018 - 2023)
Report Code : HCR 1222
Updated Date: 09 August, 2018  

1. Hemostats Market – Overview
2. Hemostats Market – Executive Summary 
3. Hemostats Market Landscape
   3.1.  Market Share Analysis
   3.2.  Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
      3.2.4. Patent Analysis
4. Hemostats Market – Forces
   4.1. Drivers
   4.2. Restraints & Challenges
   4.3. Porter’s Five Forces Analysis
      4.3.1. Bargaining Power of Suppliers
      4.3.2. Bargaining Power of Buyers
      4.3.3. Threat From New Entrants
      4.3.4. Threat From Substitutes Products
      4.3.5. Degree of Competition
5. Hemostats Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product Life Cycle
6. Hemostats Market – By Type
   6.1. Introduction 
   6.2. Active
      6.2.1. Thrombin Based Hemostat 
            6.2.1.1. Bovine Thrombin 
            6.2.1.2. Pooled Human Plasma Thrombin
            6.2.1.3. Recombinant Thrombin
   6.3. Passive
      6.3.1. Collagen Based Hemostats
            6.3.1.1. Microfibrillar Collagen Hemostat
            6.3.1.2. Absorbable Collagen Hemostat Sponge
      6.3.2. Oxidized Regenerated Cellulose
      6.3.3. Gelatins
      6.3.4. Polysacchride Hemospheres
   6.4. Flowable
      6.4.1. Bovine Gelatin & Pooled Human Thrombin
      6.4.2. Bovine Gelatin + Other Thrombin Products
   6.5.  Sealants 
      6.5.1. Fibrin Sealants
      6.5.2. Synthetic Sealants
      6.5.3.  Others
   6.6. Adhesive
      6.6.1. Polyethylene Glycol Hydrogels (PEG)
      6.6.2.  PEG + Trilysine Amine
      6.6.3. PEG + Human Serum Albumin
      6.6.4. Liquid Monomers
7. Hemostats Market – By Treatment
   7.1. Introduction 
   7.2. Cardiac Surgery
   7.3. Vascular Procedures
   7.4. Soft Tissue Reconstruction
   7.5. Spinal Procedures
   7.6. Hepatic Resection
   7.7. Others 
8. Hemostats Market – By End User
   8.1. Introduction 
   8.2. Hospitals
   8.3. Surgery Centers
   8.4. Nursing Homes
   8.5. Others 
9. Hemostats Market – By Geography
   9.1. Introduction
   9.2. Americas
      9.2.1. U.S.
      9.2.2. Canada
      9.2.3. Brazil
      9.2.4. Mexico
      9.2.5. Rest of Americas
   9.3. Europe
      9.3.1. Germany
      9.3.2. U.K.
      9.3.3. France
      9.3.4. Italy
      9.3.5. Rest of Europe
   9.4. Asia Pacific
      9.4.1. China
      9.4.2. Japan
      9.4.3. India
      9.4.4. Rest of APAC
   9.5. Rest of the World
      9.5.1. Middle East
      9.5.2. Africa
10. Hemostats – Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs, Partnership
11. Hemostats Market Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Baxter International Inc.
   11.2. Vascular Solutions Inc. 
   11.3. 3-D Matrix Ltd. 
   11.4. Resorba Medical GmbH 
   11.5. Anika Therapeutics
   11.6. Arch Therapeutics Inc.
   11.7. Johnson and Johnson 
   11.8. C. R. Bard, Inc. 
   11.9. Pfizer Inc. 
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll